搜索页_+Ian+Flinn

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“Elsevier电子期刊”中，命中：13条，耗时：小于0.01 秒

在所有数据库中总计命中：295条

1.Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes

作者：Christopher R. Flowers¹ ; Luciano J. Costa² ; Marcelo C. Pasquini³ ; Jennifer Le-Rademacher³ ; Michael Lill⁴ ; Tsiporah B. Shore⁵ ; William Vaughan⁶ ; Michael Craig⁷ ; Cesar O. Freytes⁸ ; Thomas C. Shea⁹ ; Mitchell E. Horwitz¹⁰ ; Joseph W. Fay¹¹ ; Shin Mineishi¹² ; Damiano Rondelli¹³ ; James Mason¹⁴ ; Ira Braunschweig¹⁵ ; Weiyun Ai¹⁶ ; Rosa F. Yeh¹⁷ ; Tulio E. Rodriguez¹⁸ ; Ian Flinn¹⁹ ; Terrance Comeau²⁰ ; Andrew M. Yeager²¹ ; Michael A. Pulsipher²² ; Isabelle Bence-Bruckler²³ ; Pierre Laneuville²⁴ ; Philip Bierman²⁵ ; Andy I. Chen²⁶ ; Kazunobu Kato²⁷ ; Yanlin Wang²⁷ ; Cong Xu²⁷ ; Angela J. Smith²⁷ ; Edmund K. Waller¹ ; ^{ewaller@emory.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：Non-Hodgkin lymphoma ; Hodgkin lymphoma ; Busulfan ; Autologous stem cell transplantation ; Stem cell transplantation ; Lymphoma ; Chemotherapy

刊名：Biology of Blood and Marrow Transplantation

出版年：2016

2.Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial

作者：Dr Anas Younes ; MD^a ; ^{younesa@mskcc.org" class="auth_mail" title="E-mail the corresponding author} ; Jesus G Berdeja ; MD^b ; Manish R Patel ; MD^b ; ^c ; Ian Flinn ; MD^b ; John F Gerecitano ; MD^a ; Sattva S Neelapu ; MD^d ; Kevin R Kelly ; MD^e ; Amanda R Copeland ; MSN^a ; Amy Akins ; BSN^b ; Myles S Clancy ; MBA^f ; Lucy Gong ; PharmD^f ; Jing Wang ; PhD^f ; Anna Ma ; MS^f ; Jaye L Viner ; MD^f ; Yasuhiro Oki ; MD^d

刊名：The Lancet Oncology

出版年：2016

3.The expanding options for front-line treatment in patients with newly diagnosed CML

作者：Javier Pinilla-Ibarz ; Ian Flinn

关键词：Imatinib ; Nilotinib ; Dasatinib ; Chronic myeloid leukemia ; Tyrosine kinase therapy ; Front-line setting

刊名：Critical Reviews in Oncology/Hematology

出版年：2012

4.Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial

作者：Prof Hagop M Kantarjian ; MD^a ; ^{hkantarj@mdanderson.org} ; Prof Andreas Hochhaus ; MD^b ; Prof Giuseppe Saglio ; MD^c ; Prof Carmino De Souza ; MD^d ; Ian W Flinn ; MD^e ; Leif Stenke ; MD^f ; ^g ; Yeow-Tee Goh ; MD^h ; Prof Gianantonio Rosti ; MDⁱ ; Hirohisa Nakamae ; MD^j ; Neil J Gallagher ; MD^k ; Albert Hoenekopp ; MD^k ; Rick E Blakesley ; PhD^l ; Prof Richard A Larson ; MD^m ; Prof Timothy P Hughes ; MDⁿ

刊名：Lancet Oncology

出版年：2011

5.5.30 Preliminary Results from a Phase I/II Study of Fludarabine (F), Rituximab (R), and Lenalidomide (L) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

作者：Ian W. Flinn¹ ; ² ; Ines M. Macias-Perez¹ ; Patrick S. Tucker¹ ; R. Seth Cooper² ; Habib H. Doss² ; Dana S. Thompson² ; Jesus G. Berdeja¹ ; ² ; John D. Hainsworth¹ ; ²

刊名：Clinical Lymphoma Myeloma and Leukemia

出版年：2011

6.5.43 Patterns of Nodal Response and Lymphocytosis in Patients with Previously Treated CLL Receiving the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K¦Ä) Inhibitor, CAL-101 (GS-1101) Alone or in Combination with Rituximab (R) or Bendamustine (B)

作者：Jennifer R. Brown¹ ; Thomas M. Jahn² ; Richard R. Furman³ ; John P. Leonard³ ; Stephen E. Spurgeon⁴ ; John C. Byrd⁵ ; Don M. Benson⁵ ; Steven E. Coutre⁶ ; Nina D. Wagner-Johnston⁷ ; Ian W. Flinn⁸ ; Brad S. Kahl⁹ ; Marshall T. Schreeder¹⁰ ; Sven de Vos¹¹ ; Leanne M. Holes² ; Harriet (Sissy) Peterman² ; Dave M. Johnson² ; Langdon L. Miller²

刊名：Clinical Lymphoma Myeloma and Leukemia

出版年：2011

7.Management of symptomatic, untreated chronic lymphocytic leukemia

作者：Yvette L. Kasamon ; Ian W. Flinn

关键词：Chronic lymphocytic leukemia (CLL) ; Fludarabine ; Rituximab ; Alemtuzumab

刊名：Blood Reviews

出版年：2007

8.Synthesis and evaluation of cis-hexahydropyrrolo[3,2-b]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinases

作者：Quibell ; Martin ; Benn ; Alex ; Flinn ; Nick ; Monk ; Tracy ; Ramjee ; Manoj ; Ray ; Peter ; Wang ; Yikang ; et. al.

关键词：CAC1 proteinase inhibition ; Bicyclic ketones ; Anti-resorptive

刊名：Bioorganic and Medicinal Chemistry

出版年：2005

9.Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity

作者：Ian W. Flinn ; John C. Byrd ; Nancy Bartlett ; Thomas Kipps ; John Gribben ; Deborah Thomas ; Richard A. Larson ; Kanti Rai ; Rosemary Petric ; Jose Ramon-Suerez et al.

刊名：Leukemia Research

出版年：2005

10.Incorporating monoclonal antibodies in blood and marrow transplantation

作者：Sami N Malek^a ; Ian W Flinn ; ^a

刊名：Seminars in Oncology

出版年：2003

按检索点细分(13)

作者(12)

按出版年细分(13)

2016年(2)

2012年(1)

2011年(3)

2007年(1)

2005年(2)

2003年(1)

2001年(2)

2000年及以前(1)